CEFOTAXIME

CEFOTAXIME was reported 4349 times

CEFOTAXIME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARECHOVIRUS INFECTION 4 0.3636
1 UMBILICAL ERYTHEMA 12 0.1967
2 KOCURIA INFECTION 3 0.1875
3 SERRATIA SEPSIS 14 0.1296
4 HEPATOSPLENOMEGALY NEONATAL 5 0.1190
5 HIV ASSOCIATED NEPHROPATHY 6 0.1176
6 COAGULATION FACTOR V LEVEL INCREASED 3 0.1154
7 NEONATAL INTESTINAL PERFORATION 4 0.1111
8 URETHRAL VALVES 9 0.0968
9 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 3 0.0968
10 PANTOEA AGGLOMERANS INFECTION 5 0.0649
11 ADRENAL CORTICAL INSUFFICIENCY 2 0.0606
12 LISTERIA ENCEPHALITIS 6 0.0526
13 LUNG ASSIST DEVICE THERAPY 3 0.0484
14 ANTIBIOTIC LEVEL BELOW THERAPEUTIC 4 0.0392
15 FEVER NEONATAL 5 0.0382
16 BLOOD SMEAR TEST ABNORMAL 3 0.0375
17 ATELECTASIS NEONATAL 4 0.0370
18 SUPRAVENTRICULAR TACHYARRHYTHMIA 5 0.0355
19 POLYMERASE CHAIN REACTION 4 0.0354
20 NEONATAL CARDIAC FAILURE 3 0.0333
21 PULMONARY HAEMORRHAGE NEONATAL 3 0.0326
22 TOXIC SHOCK SYNDROME STREPTOCOCCAL 6 0.0311
23 RESTRICTIVE CARDIOMYOPATHY 9 0.0297
24 NECROTISING ENTEROCOLITIS NEONATAL 12 0.0296
25 RETICULOCYTOSIS 6 0.0283
26 DISSEMINATED CYTOMEGALOVIRAL INFECTION 6 0.0278
27 RED BLOOD CELL SCHISTOCYTES PRESENT 9 0.0278
28 ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC 2 0.0267
29 MYCOPLASMA TEST POSITIVE 4 0.0263
30 CSF WHITE BLOOD CELL COUNT INCREASED 5 0.0262
31 CD4 LYMPHOCYTES INCREASED 6 0.0258
32 ENTEROBACTER PNEUMONIA 4 0.0256
33 CENTRAL NERVOUS SYSTEM NECROSIS 7 0.0254
34 VASCULAR ACCESS SITE HAEMORRHAGE 4 0.0248
35 NEONATAL SEIZURE 6 0.0241
36 CARNITINE DEFICIENCY 4 0.0234
37 DYSBACTERIOSIS 5 0.0234
38 CLOSTRIDIUM BACTERAEMIA 5 0.0234
39 ADAMTS13 ACTIVITY DECREASED 6 0.0232
40 EOSINOPENIA 3 0.0227
41 LARYNGEAL STENOSIS 13 0.0225
42 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 3 0.0211
43 GASTROENTERITIS ADENOVIRUS 3 0.0191
44 THROMBOCYTOPENIA NEONATAL 8 0.0190
45 SERRATIA INFECTION 14 0.0188
46 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 9 0.0185
47 CNS VENTRICULITIS 6 0.0184
48 DISSEMINATED STRONGYLOIDIASIS 4 0.0183
49 RENAL FAILURE NEONATAL 4 0.0180
50 ACHROMOBACTER INFECTION 2 0.0167
51 MENINGITIS PNEUMOCOCCAL 6 0.0164
52 RESPIRATORY GAS EXCHANGE DISORDER 6 0.0162
53 ENCEPHALITIS CYTOMEGALOVIRUS 7 0.0160
54 MYOCARDIAL DEPRESSION 4 0.0155
55 TRANSFERRIN SATURATION DECREASED 6 0.0141
56 APLASIA CUTIS CONGENITA 2 0.0140
57 NEUROPSYCHIATRIC SYNDROME 3 0.0136
58 TISSUE INFILTRATION 4 0.0136
59 PHARYNGOTONSILLITIS 3 0.0133
60 EPIDERMOLYSIS 6 0.0130
61 POST PROCEDURAL BILE LEAK 4 0.0128
62 ACID FAST BACILLI INFECTION 2 0.0124
63 SEPSIS NEONATAL 10 0.0123
64 VIBRATORY SENSE INCREASED 3 0.0118
65 PULMONARY NECROSIS 4 0.0117
66 NEOVASCULARISATION 3 0.0114
67 LIMBIC ENCEPHALITIS 3 0.0109
68 CLOSTRIDIUM COLITIS 13 0.0107
69 NEWBORN PERSISTENT PULMONARY HYPERTENSION 3 0.0107
70 MENINGISM 5 0.0107
71 STENOTROPHOMONAS INFECTION 14 0.0103
72 ACINETOBACTER TEST POSITIVE 2 0.0103
73 CATHETER SITE EXTRAVASATION 4 0.0100
74 SUBDURAL HYGROMA 3 0.0099
75 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 248 0.0096
76 VENTRICULAR FAILURE 3 0.0096
77 EPSTEIN-BARR VIRUS TEST POSITIVE 6 0.0095
78 DRUG LEVEL ABNORMAL 5 0.0094
79 TUBERCULOSIS GASTROINTESTINAL 3 0.0094
80 GASTROENTERITIS ESCHERICHIA COLI 5 0.0091
81 INTRAVASCULAR HAEMOLYSIS 5 0.0089
82 HEART TRANSPLANT 8 0.0088
83 ALVEOLITIS ALLERGIC 9 0.0087
84 BRAIN ABSCESS 22 0.0087
85 TOXIC EPIDERMAL NECROLYSIS 131 0.0086
86 HYPERBILIRUBINAEMIA NEONATAL 5 0.0086
87 PLEOCYTOSIS 5 0.0086
88 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 3 0.0085
89 VASCULITIS NECROTISING 6 0.0084
90 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0083
91 HEPATORENAL FAILURE 5 0.0083
92 ACINETOBACTER INFECTION 9 0.0082
93 CROSS SENSITIVITY REACTION 8 0.0082
94 NEONATAL HYPOTENSION 3 0.0082
95 GENERALISED BULLOUS FIXED DRUG ERUPTION 3 0.0081
96 SOFT TISSUE HAEMORRHAGE 3 0.0080
97 HEPATOCELLULAR INJURY 113 0.0080
98 HYPERLEUKOCYTOSIS 7 0.0079
99 ALKALOSIS 3 0.0079
100 CENTRAL NERVOUS SYSTEM VASCULITIS 4 0.0078
101 MESENTERIC ARTERY THROMBOSIS 3 0.0078
102 HAEMOLYTIC URAEMIC SYNDROME 18 0.0078
103 PROCALCITONIN INCREASED 9 0.0077
104 BICYTOPENIA 15 0.0076
105 RASH MORBILLIFORM 21 0.0076
106 PATENT DUCTUS ARTERIOSUS 30 0.0075
107 HAEMATOMA MUSCLE 9 0.0075
108 SKIN TEST POSITIVE 7 0.0075
109 ENTEROCOCCAL SEPSIS 6 0.0074
110 HUMAN HERPESVIRUS 6 INFECTION 14 0.0074
111 NEUROLOGICAL DECOMPENSATION 17 0.0073
112 LISTERIOSIS 8 0.0072
113 DEATH NEONATAL 10 0.0072
114 MECHANICAL ILEUS 4 0.0070
115 TYPE IV HYPERSENSITIVITY REACTION 19 0.0069
116 ABDOMINAL SEPSIS 6 0.0068
117 THERAPEUTIC PRODUCT CROSS-REACTIVITY 6 0.0067
118 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52 0.0067
119 HEART SOUNDS ABNORMAL 5 0.0067
120 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 50 0.0067
121 HEPATOSPLENOMEGALY 17 0.0066
122 FAT NECROSIS 4 0.0066
123 CEREBRAL ASPERGILLOSIS 4 0.0065
124 MYCOPLASMA INFECTION 5 0.0064
125 PNEUMONIA MYCOPLASMAL 5 0.0063
126 VENTRICULAR DYSFUNCTION 16 0.0062
127 INFANTILE APNOEA 5 0.0061
128 CLOSTRIDIUM DIFFICILE COLITIS 65 0.0061
129 IDIOSYNCRATIC DRUG REACTION 6 0.0061
130 DYSBIOSIS 5 0.0061
131 ENTEROCOCCAL INFECTION 29 0.0060
132 B-LYMPHOCYTE COUNT DECREASED 8 0.0059
133 HYPERLIPASAEMIA 3 0.0057
134 HYPOPERFUSION 6 0.0057
135 RED MAN SYNDROME 5 0.0057
136 PROPOFOL INFUSION SYNDROME 4 0.0057
137 MYCOBACTERIUM ABSCESSUS INFECTION 4 0.0056
138 MENINGITIS BACTERIAL 8 0.0056
139 CEREBRAL VENOUS THROMBOSIS 10 0.0055
140 SELECTIVE EATING DISORDER 5 0.0055
141 HAEMORRHAGIC INFARCTION 3 0.0055
142 EOSINOPHILIA 95 0.0054
143 APNOEIC ATTACK 3 0.0053
144 MIXED LIVER INJURY 16 0.0053
145 RASH MACULO-PAPULAR 116 0.0052
146 ADENOVIRUS INFECTION 15 0.0052
147 HAEMOPHILUS INFECTION 5 0.0051
148 BLOOD FIBRINOGEN INCREASED 4 0.0051
149 NEPHROCALCINOSIS 6 0.0051
150 SUPERINFECTION BACTERIAL 4 0.0050
151 URINARY TRACT INFECTION PSEUDOMONAL 3 0.0050
152 HYDROCEPHALUS 27 0.0050
153 RESPIRATORY DISORDER NEONATAL 8 0.0049
154 PERSISTENT FOETAL CIRCULATION 3 0.0049
155 FEBRILE CONVULSION 6 0.0049
156 VESTIBULAR DISORDER 6 0.0049
157 BLOOD ELECTROLYTES ABNORMAL 6 0.0049
158 PERITONEAL DIALYSIS 4 0.0048
159 CSF PROTEIN INCREASED 4 0.0048
160 VACCINATION FAILURE 8 0.0048
161 LINEAR IGA DISEASE 8 0.0048
162 TOXIC SHOCK SYNDROME 3 0.0048
163 NECROTISING COLITIS 6 0.0047
164 GASTRITIS HAEMORRHAGIC 7 0.0047
165 BLOOD PH DECREASED 8 0.0047
166 PNEUMONIA NECROTISING 3 0.0046
167 INFLAMMATORY MARKER INCREASED 23 0.0046
168 ENTEROVIRUS INFECTION 4 0.0046
169 PNEUMOCOCCAL SEPSIS 3 0.0046
170 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 6 0.0046
171 ILEAL PERFORATION 3 0.0045
172 LYMPHOCELE 3 0.0045
173 DEVICE RELATED SEPSIS 9 0.0045
174 NEONATAL DISORDER 7 0.0044
175 CUTANEOUS SYMPTOM 3 0.0044
176 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0043
177 HEPATIC CYTOLYSIS 55 0.0043
178 ANAEMIA NEONATAL 2 0.0041
179 CLONIC CONVULSION 3 0.0041
180 NOSOCOMIAL INFECTION 9 0.0041
181 RESPIRATORY ACIDOSIS 16 0.0041
182 COMA HEPATIC 3 0.0040
183 PSEUDOMEMBRANOUS COLITIS 9 0.0040
184 AGRANULOCYTOSIS 74 0.0040
185 BRADYCARDIA NEONATAL 5 0.0040
186 MUCOSAL ULCERATION 4 0.0040
187 OLIGOHYDRAMNIOS 13 0.0039
188 AKINESIA 8 0.0039
189 METAPNEUMOVIRUS INFECTION 3 0.0038
190 LIVEDO RETICULARIS 8 0.0038
191 OEDEMA MUCOSAL 4 0.0038
192 LEARNING DISORDER 9 0.0037
193 URETERIC OBSTRUCTION 5 0.0037
194 ISCHAEMIC HEPATITIS 5 0.0036
195 PULMONARY NOCARDIOSIS 3 0.0036
196 NEONATAL HYPOXIA 3 0.0036
197 FUNGAL SEPSIS 3 0.0036
198 ENDOTRACHEAL INTUBATION 10 0.0036
199 MENINGITIS ASEPTIC 16 0.0036
200 ADRENAL SUPPRESSION 3 0.0036
201 BRAIN DEATH 11 0.0036
202 KLEBSIELLA INFECTION 18 0.0036
203 CEREBRAL VENOUS SINUS THROMBOSIS 3 0.0036
204 GLOMERULAR FILTRATION RATE ABNORMAL 5 0.0035
205 FEBRILE BONE MARROW APLASIA 15 0.0035
206 KOUNIS SYNDROME 8 0.0035
207 EMPYEMA 7 0.0035
208 PURPURA 31 0.0035
209 TOXIC SKIN ERUPTION 35 0.0035
210 RECTAL ULCER 4 0.0034
211 OLIGURIA 21 0.0034
212 DRUG LEVEL FLUCTUATING 3 0.0034
213 JUGULAR VEIN THROMBOSIS 6 0.0034
214 SUBILEUS 7 0.0034
215 HYPERLACTACIDAEMIA 9 0.0034
216 CANDIDA SEPSIS 3 0.0033
217 MUCOSAL EROSION 3 0.0033
218 PATHOGEN RESISTANCE 30 0.0033
219 POOR PERIPHERAL CIRCULATION 14 0.0033
220 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
221 PSYCHOMOTOR RETARDATION 9 0.0032
222 CEREBELLAR SYNDROME 7 0.0032
223 SYSTEMIC CANDIDA 8 0.0032
224 HYPERBILIRUBINAEMIA 33 0.0032
225 NEONATAL RESPIRATORY DISTRESS 3 0.0032
226 CHOLESTATIC LIVER INJURY 7 0.0031
227 CHOLESTASIS 60 0.0031
228 PLATELET TRANSFUSION 4 0.0031
229 APGAR SCORE LOW 4 0.0031
230 BACTERIAL SEPSIS 10 0.0031
231 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
232 CELL DEATH 6 0.0030
233 MESENTERIC VEIN THROMBOSIS 3 0.0030
234 HYPOTONIA 30 0.0030
235 INTESTINAL DILATATION 4 0.0030
236 GASTRIC DILATATION 5 0.0030
237 DERMATITIS EXFOLIATIVE 15 0.0030
238 ACQUIRED HAEMOPHILIA 3 0.0030
239 MENINGITIS 20 0.0030
240 HEPATORENAL SYNDROME 5 0.0030
241 APNOEA 23 0.0030
242 FIXED ERUPTION 5 0.0029
243 ENCEPHALITIS 20 0.0029
244 HYPERTRANSAMINASAEMIA 20 0.0029
245 H1N1 INFLUENZA 4 0.0028
246 MULTIPLE ORGAN DYSFUNCTION SYNDROME 80 0.0028
247 INTENSIVE CARE 4 0.0028
248 INTRAVENTRICULAR HAEMORRHAGE 7 0.0028
249 TRANSPLANT DYSFUNCTION 5 0.0028
250 INTRA-ABDOMINAL FLUID COLLECTION 5 0.0028
251 AMNIOTIC CAVITY INFECTION 2 0.0028
252 HYPOVENTILATION 9 0.0028
253 LARGE INTESTINAL HAEMORRHAGE 6 0.0027
254 BLOOD PRESSURE IMMEASURABLE 4 0.0026
255 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 13 0.0026
256 CEREBRAL VENTRICLE DILATATION 3 0.0026
257 MUCOSAL HAEMORRHAGE 3 0.0026
258 MULTIPLE-DRUG RESISTANCE 8 0.0026
259 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 6 0.0026
260 HAEMOLYTIC ANAEMIA 23 0.0026
261 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
262 APLASIA 5 0.0026
263 MEGACOLON 4 0.0025
264 FUNGAEMIA 4 0.0025
265 STREPTOCOCCAL SEPSIS 3 0.0025
266 SEPTIC SHOCK 110 0.0025
267 NECROSIS 14 0.0025
268 PNEUMOCYSTIS JIROVECII INFECTION 3 0.0025
269 CEREBRAL ATROPHY 10 0.0025
270 ESCHERICHIA TEST POSITIVE 3 0.0025
271 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
272 APLASTIC ANAEMIA 13 0.0025
273 STRONGYLOIDIASIS 4 0.0025
274 LIVER ABSCESS 8 0.0025
275 BRAIN OEDEMA 31 0.0025
276 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
277 PALATAL OEDEMA 3 0.0024
278 QUADRIPARESIS 4 0.0024
279 STAPHYLOCOCCUS TEST POSITIVE 5 0.0024
280 POST PROCEDURAL HAEMATOMA 4 0.0024
281 THROMBOTIC MICROANGIOPATHY 23 0.0024
282 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
283 DERMATITIS BULLOUS 17 0.0023
284 BLOOD BILIRUBIN ABNORMAL 3 0.0023
285 FEMALE GENITAL TRACT FISTULA 4 0.0023
286 HAEMOLYSIS 18 0.0023
287 HYPERCAPNIA 7 0.0023
288 TONIC CLONIC MOVEMENTS 3 0.0023
289 FOETAL GROWTH RESTRICTION 14 0.0023
290 DRUG CLEARANCE DECREASED 3 0.0023
291 PREMATURE BABY 69 0.0023
292 AZOTAEMIA 9 0.0023
293 ENTEROCOLITIS 13 0.0022
294 STATUS EPILEPTICUS 25 0.0022
295 HYPERNATRAEMIA 11 0.0022
296 ENCEPHALOPATHY 54 0.0022
297 CLONUS 6 0.0022
298 PNEUMONIA BACTERIAL 20 0.0022
299 STUPOR 7 0.0022
300 CENTRAL NERVOUS SYSTEM LYMPHOMA 3 0.0022
301 PANCREATITIS NECROTISING 5 0.0022
302 EOSINOPHIL COUNT INCREASED 18 0.0022
303 INTRACRANIAL PRESSURE INCREASED 12 0.0022
304 VASCULAR PURPURA 3 0.0021
305 DRUG RESISTANCE 55 0.0021
306 HYPERPYREXIA 9 0.0021
307 LONG QT SYNDROME 5 0.0021
308 RENAL INFARCT 3 0.0021
309 CLOSTRIDIAL INFECTION 7 0.0021
310 GASTROINTESTINAL NECROSIS 6 0.0021
311 ABDOMINAL WALL HAEMATOMA 4 0.0020
312 GLOMERULONEPHRITIS 5 0.0020
313 HEPATITIS FULMINANT 6 0.0020
314 HISTIOCYTOSIS HAEMATOPHAGIC 6 0.0020
315 HEPATITIS ACUTE 13 0.0020
316 METABOLIC ENCEPHALOPATHY 6 0.0020
317 THROMBOPHLEBITIS 7 0.0020
318 CONTRAINDICATION TO MEDICAL TREATMENT 3 0.0020
319 COAGULATION TIME PROLONGED 3 0.0019
320 STEVENS-JOHNSON SYNDROME 43 0.0019
321 TRANSAMINASES INCREASED 43 0.0019
322 SKIN NECROSIS 10 0.0019
323 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
324 HYPOTONIA NEONATAL 3 0.0019
325 CUTANEOUS VASCULITIS 7 0.0019
326 HYPERPHOSPHATAEMIA 4 0.0019
327 HEPATIC NECROSIS 7 0.0019
328 RESPIRATORY ALKALOSIS 3 0.0018
329 HYPERTHERMIA 14 0.0018
330 RENAL TUBULAR ACIDOSIS 4 0.0018
331 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
332 HEPARIN-INDUCED THROMBOCYTOPENIA 9 0.0018
333 LEUKOCYTOSIS 33 0.0018
334 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
335 MITRAL VALVE PROLAPSE 3 0.0018
336 HYPERAMMONAEMIA 9 0.0018
337 CARDIOPULMONARY FAILURE 7 0.0018
338 DISTRIBUTIVE SHOCK 4 0.0018
339 COAGULOPATHY 29 0.0017
340 ACUTE PRERENAL FAILURE 2 0.0017
341 METHAEMOGLOBINAEMIA 4 0.0017
342 DERMATITIS EXFOLIATIVE GENERALISED 6 0.0017
343 ESCHERICHIA SEPSIS 5 0.0017
344 ELECTROLYTE IMBALANCE 20 0.0017
345 ACUTE LUNG INJURY 2 0.0017
346 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
347 ASPERGILLUS INFECTION 11 0.0017
348 HYPOGAMMAGLOBULINAEMIA 11 0.0017
349 BLOOD CULTURE POSITIVE 5 0.0017
350 DIABETES INSIPIDUS 4 0.0017
351 NASAL OEDEMA 3 0.0017
352 CEREBROVASCULAR DISORDER 5 0.0017
353 LYMPHADENITIS 4 0.0017
354 LOW BIRTH WEIGHT BABY 13 0.0016
355 INTESTINAL ISCHAEMIA 9 0.0016
356 PNEUMONIA KLEBSIELLA 3 0.0016
357 TRANSPLANT FAILURE 4 0.0016
358 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
359 RESPIRATORY DISTRESS 45 0.0016
360 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
361 STAPHYLOCOCCAL SEPSIS 8 0.0016
362 CANDIDA INFECTION 27 0.0016
363 POLYURIA 13 0.0016
364 ILEUS PARALYTIC 7 0.0016
365 ENDOCARDITIS 8 0.0016
366 HYPOALBUMINAEMIA 12 0.0015
367 ASPERGILLOSIS 2 0.0015
368 PYELONEPHRITIS ACUTE 3 0.0015
369 TORSADE DE POINTES 12 0.0015
370 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
371 BLOOD LACTIC ACID INCREASED 8 0.0015
372 PSEUDOMONAS INFECTION 13 0.0015
373 ERYTHEMA MULTIFORME 14 0.0015
374 AREFLEXIA 4 0.0015
375 ANION GAP INCREASED 2 0.0015
376 CANDIDIASIS 6 0.0015
377 HEPATITIS CHOLESTATIC 9 0.0015
378 ACCIDENTAL POISONING 2 0.0015
379 ACUTE CORONARY SYNDROME 12 0.0014
380 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
381 HAEMODYNAMIC INSTABILITY 11 0.0014
382 HYPERREFLEXIA 5 0.0014
383 LYMPHOPENIA 20 0.0014
384 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
385 FIBRIN D DIMER INCREASED 5 0.0014
386 TACHYPNOEA 19 0.0014
387 ANURIA 12 0.0014
388 THROMBOCYTOPENIA 155 0.0014
389 PANCYTOPENIA 77 0.0014
390 GENERALISED OEDEMA 17 0.0014
391 THROMBOCYTOSIS 5 0.0014
392 STRIDOR 4 0.0014
393 PARADOXICAL DRUG REACTION 5 0.0014
394 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
395 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
396 SHOCK HAEMORRHAGIC 11 0.0013
397 ELECTROCARDIOGRAM QT PROLONGED 48 0.0013
398 DERMATITIS ACNEIFORM 8 0.0013
399 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
400 HAEMODIALYSIS 11 0.0013
401 ISCHAEMIA 6 0.0013
402 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
403 FACE OEDEMA 22 0.0013
404 DUODENITIS 4 0.0013
405 RENAL FUNCTION TEST ABNORMAL 6 0.0013
406 BILIRUBIN CONJUGATED INCREASED 3 0.0013
407 ACUTE KIDNEY INJURY 196 0.0013
408 CYANOSIS 20 0.0013
409 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
410 COVID-19 PNEUMONIA 15 0.0013
411 NEUTROPHIL COUNT INCREASED 13 0.0013
412 OXYGEN CONSUMPTION INCREASED 3 0.0013
413 PNEUMONIA VIRAL 4 0.0013
414 METABOLIC ACIDOSIS 40 0.0012
415 PULMONARY HYPERTENSION 26 0.0012
416 PETECHIAE 13 0.0012
417 RASH VESICULAR 6 0.0012
418 PERIPHERAL ISCHAEMIA 5 0.0012
419 LEUKOPENIA 61 0.0012
420 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
421 CYTOMEGALOVIRUS INFECTION 20 0.0012
422 ALTERED STATE OF CONSCIOUSNESS 26 0.0012
423 PNEUMOCYSTIS JIROVECII PNEUMONIA 12 0.0012
424 BONE MARROW FAILURE 24 0.0012
425 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
426 BUNDLE BRANCH BLOCK LEFT 5 0.0012
427 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
428 NOCARDIOSIS 3 0.0012
429 HEPATITIS 30 0.0012
430 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
431 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
432 SEPSIS 130 0.0012
433 MUCORMYCOSIS 3 0.0012
434 LARGE INTESTINE PERFORATION 8 0.0012
435 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
436 URINE OUTPUT DECREASED 10 0.0011
437 ORAL CANDIDIASIS 15 0.0011
438 TYPE I HYPERSENSITIVITY 4 0.0011
439 JAUNDICE CHOLESTATIC 4 0.0011
440 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
441 ANAPHYLACTIC SHOCK 29 0.0011
442 HEPATOMEGALY 11 0.0011
443 CIRCULATORY COLLAPSE 19 0.0011
444 NEUTROPENIA 150 0.0011
445 VASCULAR DEVICE INFECTION 5 0.0011
446 MULTI-ORGAN FAILURE 19 0.0011
447 ORAL FUNGAL INFECTION 3 0.0011
448 BACTERAEMIA 13 0.0011
449 FAECALOMA 6 0.0011
450 DRUG ERUPTION 19 0.0011
451 C-REACTIVE PROTEIN INCREASED 39 0.0011
452 ADENOCARCINOMA OF COLON 2 0.0011
453 RENAL TUBULAR DISORDER 3 0.0011
454 ABSCESS 17 0.0011
455 CATHETER SITE INFECTION 4 0.0011
456 PNEUMATOSIS INTESTINALIS 3 0.0011
457 BRONCHOSPASM 15 0.0011
458 HYPERTONIA 6 0.0010
459 ACIDOSIS 8 0.0010
460 CARDIOGENIC SHOCK 15 0.0010
461 SHOCK 24 0.0010
462 HYPOKALAEMIA 48 0.0010
463 SUDDEN DEATH 11 0.0010
464 HAEMOTHORAX 3 0.0010
465 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
466 ATROPHY 2 0.0010
467 HYPERKALAEMIA 36 0.0010
468 PANCREATITIS ACUTE 23 0.0010
469 PULMONARY HAEMORRHAGE 8 0.0010
470 RENAL TUBULAR NECROSIS 10 0.0010
471 LACTIC ACIDOSIS 33 0.0010
472 BREATH SOUNDS ABNORMAL 5 0.0010
473 MYOCLONUS 12 0.0010
474 INFUSION SITE REACTION 3 0.0010
475 BRAIN HERNIATION 3 0.0010
476 MUSCLE RIGIDITY 12 0.0010
477 ATYPICAL PNEUMONIA 3 0.0010
478 MYOSITIS 9 0.0010
479 TRANSPLANT REJECTION 8 0.0010
480 FOETAL EXPOSURE DURING PREGNANCY 81 0.0010
481 PULMONARY TOXICITY 7 0.0010
482 ACUTE RESPIRATORY FAILURE 19 0.0010
483 TOXIC ENCEPHALOPATHY 5 0.0010
484 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
485 PULMONARY CONGESTION 13 0.0010
486 MASTICATION DISORDER 3 0.0010
487 NEPHROPATHY TOXIC 11 0.0010
488 HICCUPS 8 0.0010
489 EXTRAVASATION 4 0.0010
490 CEREBRAL ISCHAEMIA 5 0.0010
491 HYPOXIA 34 0.0010
492 GASTROINTESTINAL PERFORATION 4 0.0010
493 HEPATIC FAILURE 29 0.0010
494 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
495 MOUTH HAEMORRHAGE 7 0.0010
496 RESPIRATORY FAILURE 69 0.0009
497 PNEUMOTHORAX 15 0.0009
498 NYSTAGMUS 5 0.0009
499 ANAL FISTULA 5 0.0009
500 BLOOD CREATININE INCREASED 61 0.0009
501 BODY TEMPERATURE INCREASED 19 0.0009
502 ATAXIA 11 0.0009
503 PYELONEPHRITIS 8 0.0009
504 NEUROTOXICITY 16 0.0009
505 RHABDOMYOLYSIS 38 0.0009
506 CYTOLYTIC HEPATITIS 3 0.0009
507 STREPTOCOCCAL INFECTION 5 0.0009
508 WOUND DEHISCENCE 3 0.0009
509 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
510 SUSPECTED OFF LABEL USE 4 0.0009
511 B-CELL LYMPHOMA 3 0.0009
512 PERITONITIS 18 0.0009
513 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
514 LOCALISED OEDEMA 4 0.0009
515 RALES 5 0.0009
516 STRESS CARDIOMYOPATHY 5 0.0009
517 HEPATIC ENCEPHALOPATHY 8 0.0009
518 DIARRHOEA HAEMORRHAGIC 8 0.0009
519 HYPERTRIGLYCERIDAEMIA 5 0.0009
520 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
521 BRONCHIOLITIS 3 0.0009
522 PLATELET COUNT INCREASED 11 0.0008
523 NEUROLEPTIC MALIGNANT SYNDROME 10 0.0008
524 PLEURISY 5 0.0008
525 CONJUNCTIVAL HYPERAEMIA 3 0.0008
526 PROTEINURIA 16 0.0008
527 LIVE BIRTH 7 0.0008
528 LIVER DISORDER 37 0.0008
529 KIDNEY TRANSPLANT REJECTION 4 0.0008
530 PYREXIA 286 0.0008
531 BLOOD PHOSPHORUS DECREASED 3 0.0008
532 PREMATURE DELIVERY 13 0.0008
533 RESPIRATORY DEPRESSION 10 0.0008
534 ORGANISING PNEUMONIA 4 0.0008
535 CORONARY ARTERY STENOSIS 4 0.0008
536 LUNG INFILTRATION 7 0.0008
537 LYMPHADENOPATHY 28 0.0008
538 VENTRICULAR TACHYCARDIA 13 0.0008
539 SCREAMING 5 0.0008
540 ENTERITIS 5 0.0008
541 SKIN REACTION 11 0.0008
542 FEMORAL NECK FRACTURE 4 0.0008
543 CACHEXIA 4 0.0008
544 BLOOD UREA INCREASED 13 0.0008
545 PALLOR 21 0.0008
546 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
547 HEMIPARESIS 13 0.0008
548 OXYGEN SATURATION DECREASED 43 0.0008
549 VENOUS THROMBOSIS 3 0.0008
550 UROSEPSIS 7 0.0008
551 SERUM FERRITIN INCREASED 4 0.0008
552 BLOOD ALBUMIN DECREASED 6 0.0008
553 BRADYCARDIA 40 0.0008
554 RENAL FAILURE ACUTE 32 0.0008
555 CHEILITIS 4 0.0007
556 INFARCTION 5 0.0007
557 ASPIRATION 8 0.0007
558 HYPERURICAEMIA 3 0.0007
559 HYPERKERATOSIS 4 0.0007
560 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
561 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
562 RASH PAPULAR 16 0.0007
563 ACUTE PULMONARY OEDEMA 4 0.0007
564 RASH ERYTHEMATOUS 34 0.0007
565 PAPULE 5 0.0007
566 PREMATURE LABOUR 4 0.0007
567 DRUG-INDUCED LIVER INJURY 22 0.0007
568 CEREBRAL HAEMORRHAGE 25 0.0007
569 BRAIN INJURY 7 0.0007
570 BACTERIAL INFECTION 13 0.0007
571 RASH GENERALISED 18 0.0007
572 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
573 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
574 CARDIO-RESPIRATORY ARREST 29 0.0007
575 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
576 RENAL FAILURE 91 0.0007
577 PNEUMONIA ASPIRATION 17 0.0007
578 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
579 KETOACIDOSIS 5 0.0007
580 IRON DEFICIENCY 3 0.0007
581 DRUG LEVEL INCREASED 11 0.0007
582 TACHYCARDIA 59 0.0007
583 DRUG INTERACTION 105 0.0007
584 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
585 LIPASE INCREASED 5 0.0007
586 CHOLANGITIS 4 0.0006
587 CARDIAC ARREST 53 0.0006
588 ASPARTATE AMINOTRANSFERASE INCREASED 34 0.0006
589 ANAEMIA 121 0.0006
590 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
591 PRE-ECLAMPSIA 3 0.0006
592 COMA 30 0.0006
593 APHASIA 19 0.0006
594 SUBDURAL HAEMATOMA 9 0.0006
595 PNEUMONITIS 17 0.0006
596 INTESTINAL PERFORATION 7 0.0006
597 GASTROENTERITIS 9 0.0006
598 HEPATIC FUNCTION ABNORMAL 23 0.0006
599 MYOCARDIAL ISCHAEMIA 7 0.0006
600 ABNORMAL FAECES 5 0.0006
601 OEDEMA 33 0.0006
602 FLUID INTAKE REDUCED 3 0.0006
603 HYPOTHERMIA 6 0.0006
604 AMMONIA INCREASED 3 0.0006
605 DEVICE RELATED INFECTION 9 0.0006
606 RENAL IMPAIRMENT 49 0.0006
607 EXPOSURE DURING PREGNANCY 36 0.0006
608 PERIORBITAL OEDEMA 3 0.0006
609 VENTRICULAR EXTRASYSTOLES 6 0.0006
610 HYPOGLYCAEMIA 28 0.0006
611 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
612 MUCOSAL INFLAMMATION 15 0.0006
613 PARTIAL SEIZURES 3 0.0006
614 PHARYNGOLARYNGEAL PAIN 3 0.0006
615 WRONG DRUG ADMINISTERED 5 0.0006
616 PULMONARY OEDEMA 25 0.0006
617 GRAFT VERSUS HOST DISEASE 4 0.0006
618 LETHARGY 32 0.0006
619 COLITIS 21 0.0006
620 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 30 0.0005
621 ASCITES 16 0.0005
622 GRAND MAL CONVULSION 5 0.0005
623 MEDICAL DEVICE COMPLICATION 4 0.0005
624 HAEMOPTYSIS 15 0.0005
625 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
626 ANGIOPATHY 3 0.0005
627 RESPIRATORY DISORDER 16 0.0005
628 LIVER INJURY 13 0.0005
629 CHOLECYSTITIS ACUTE 3 0.0005
630 GENERALISED ERYTHEMA 3 0.0005
631 GRANULOCYTOPENIA 3 0.0005
632 PLEURAL EFFUSION 32 0.0005
633 PULMONARY FIBROSIS 10 0.0005
634 HYPOTENSION 104 0.0005
635 ATELECTASIS 5 0.0005
636 SINUS BRADYCARDIA 5 0.0005
637 METABOLIC DISORDER 3 0.0005
638 DYSTONIA 10 0.0005
639 VASCULITIS 6 0.0005
640 HYPOVOLAEMIA 3 0.0005
641 FEBRILE NEUTROPENIA 34 0.0005
642 ACUTE HEPATIC FAILURE 7 0.0005
643 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
644 BLOOD IRON DECREASED 6 0.0005
645 PROTHROMBIN TIME PROLONGED 3 0.0005
646 OSTEOMYELITIS 9 0.0005
647 ARTHRITIS BACTERIAL 2 0.0005
648 ESCHERICHIA INFECTION 4 0.0005
649 RASH MACULAR 17 0.0005
650 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
651 HYPERCALCAEMIA 6 0.0005
652 INFLAMMATION 25 0.0005
653 HEPATIC STEATOSIS 9 0.0005
654 ILEUS 6 0.0005
655 INFUSION SITE EXTRAVASATION 3 0.0005
656 LIVER FUNCTION TEST ABNORMAL 14 0.0005
657 INTERSTITIAL LUNG DISEASE 23 0.0005
658 INFUSION SITE ERYTHEMA 4 0.0005
659 HALLUCINATION, VISUAL 10 0.0005
660 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
661 MYDRIASIS 6 0.0005
662 THERAPY NON-RESPONDER 21 0.0005
663 MYOPATHY 4 0.0005
664 CARDIAC MURMUR 4 0.0005
665 CONDITION AGGRAVATED 140 0.0005
666 TUMOUR LYSIS SYNDROME 4 0.0005
667 CORONAVIRUS INFECTION 3 0.0005
668 CARDIAC FAILURE ACUTE 3 0.0004
669 CARDIOTOXICITY 4 0.0004
670 MALNUTRITION 5 0.0004
671 JAUNDICE 12 0.0004
672 COLITIS ISCHAEMIC 3 0.0004
673 DEVELOPMENTAL DELAY 4 0.0004
674 MITRAL VALVE INCOMPETENCE 5 0.0004
675 GINGIVAL BLEEDING 6 0.0004
676 HAEMATURIA 15 0.0004
677 ECCHYMOSIS 3 0.0004
678 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
679 STAPHYLOCOCCAL INFECTION 14 0.0004
680 CARDIAC FAILURE 34 0.0004
681 HYPOCALCAEMIA 8 0.0004
682 PRODUCT PRESCRIBING ERROR 10 0.0004
683 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
684 NERVOUS SYSTEM DISORDER 13 0.0004
685 FLUID OVERLOAD 6 0.0004
686 ADRENAL INSUFFICIENCY 5 0.0004
687 RASH PUSTULAR 3 0.0004
688 HYPERGLYCAEMIA 15 0.0004
689 VITAMIN D DEFICIENCY 4 0.0004
690 DRUG WITHDRAWAL SYNDROME NEONATAL 6 0.0004
691 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
692 EPISTAXIS 30 0.0004
693 SALIVARY HYPERSECRETION 4 0.0004
694 GENERAL PHYSICAL HEALTH DETERIORATION 46 0.0004
695 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
696 LYMPHOCYTE COUNT DECREASED 7 0.0004
697 PRODUCT ADMINISTRATION ERROR 8 0.0004
698 HEPATOCELLULAR CARCINOMA 3 0.0004
699 TROPONIN INCREASED 3 0.0004
700 DRUG LEVEL DECREASED 4 0.0004
701 EPILEPSY 12 0.0004
702 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
703 HYPONATRAEMIA 22 0.0004
704 RENAL FAILURE CHRONIC 3 0.0004
705 ATRIOVENTRICULAR BLOCK 3 0.0004
706 LUNG DISORDER 19 0.0004
707 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
708 TRANSFUSION 4 0.0004
709 OFF LABEL USE 334 0.0004
710 ATRIAL FLUTTER 3 0.0004
711 MIOSIS 3 0.0004
712 RHINITIS 3 0.0004
713 SKIN LESION 10 0.0004
714 POST PROCEDURAL COMPLICATION 7 0.0004
715 SEROTONIN SYNDROME 7 0.0004
716 VENTRICULAR FIBRILLATION 4 0.0004
717 HYPOMAGNESAEMIA 5 0.0004
718 ATRIAL SEPTAL DEFECT 3 0.0004
719 DIALYSIS 5 0.0004
720 PULMONARY EMBOLISM 33 0.0003
721 DYSARTHRIA 13 0.0003
722 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
723 ANAPHYLACTIC REACTION 19 0.0003
724 CAESAREAN SECTION 4 0.0003
725 SPINAL OSTEOARTHRITIS 3 0.0003
726 SPLENOMEGALY 4 0.0003
727 IMMUNOSUPPRESSION 3 0.0003
728 ISCHAEMIC STROKE 6 0.0003
729 IMMUNODEFICIENCY 5 0.0003
730 HAEMORRHAGE INTRACRANIAL 5 0.0003
731 URINARY RETENTION 11 0.0003
732 ACCIDENTAL OVERDOSE 12 0.0003
733 CEREBRAL INFARCTION 8 0.0003
734 IRON DEFICIENCY ANAEMIA 3 0.0003
735 EJECTION FRACTION DECREASED 5 0.0003
736 BLOOD SODIUM DECREASED 6 0.0003
737 MELAENA 7 0.0003
738 ANGIOEDEMA 14 0.0003
739 HAEMATEMESIS 8 0.0003
740 HEPATOTOXICITY 7 0.0003
741 MOVEMENT DISORDER 10 0.0003
742 CHROMATURIA 7 0.0003
743 RESPIRATORY TRACT INFECTION 8 0.0003
744 DEAFNESS 8 0.0003
745 PNEUMONIA 99 0.0003
746 ANHEDONIA 8 0.0003
747 PERICARDIAL EFFUSION 7 0.0003
748 CONVULSION 17 0.0003
749 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
750 STOMATITIS 18 0.0003
751 NEUTROPHIL COUNT DECREASED 12 0.0003
752 DRUG TOXICITY 4 0.0003
753 METRORRHAGIA 5 0.0003
754 INFECTION 42 0.0003
755 POOR VENOUS ACCESS 3 0.0003
756 OEDEMA PERIPHERAL 35 0.0003
757 PRODUCT USE IN UNAPPROVED INDICATION 71 0.0003
758 DERMATITIS 6 0.0003
759 FOLLICULITIS 3 0.0003
760 APPLICATION SITE REACTION 2 0.0003
761 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
762 IRRITABILITY 17 0.0003
763 DRUG INEFFECTIVE 372 0.0003
764 LIVER FUNCTION TEST INCREASED 6 0.0003
765 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
766 RASH 121 0.0003
767 FAECES DISCOLOURED 6 0.0003
768 OESOPHAGITIS 3 0.0003
769 IMPAIRED HEALING 9 0.0003
770 THROMBOSIS 22 0.0003
771 HAEMATOMA 7 0.0003
772 BLISTER 15 0.0003
773 BLOOD CALCIUM DECREASED 3 0.0003
774 PHOTOPHOBIA 5 0.0003
775 FEAR 7 0.0003
776 CONFUSIONAL STATE 42 0.0003
777 BLOOD BILIRUBIN INCREASED 7 0.0003
778 AGITATION 19 0.0003
779 ABDOMINAL DISTENSION 27 0.0003
780 ERYTHEMA 53 0.0003
781 TOXICITY TO VARIOUS AGENTS 43 0.0003
782 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
783 SEIZURE 29 0.0003
784 MYELOSUPPRESSION 9 0.0002
785 SYNCOPE 25 0.0002
786 HEPATIC ENZYME INCREASED 17 0.0002
787 CYTOKINE RELEASE SYNDROME 5 0.0002
788 SKIN EXFOLIATION 21 0.0002
789 CRYING 9 0.0002
790 BLOOD POTASSIUM INCREASED 4 0.0002
791 DEEP VEIN THROMBOSIS 16 0.0002
792 NO THERAPEUTIC RESPONSE 3 0.0002
793 ANGINA PECTORIS 7 0.0002
794 CARDIOMEGALY 3 0.0002
795 PHARYNGITIS 3 0.0002
796 URTICARIA 40 0.0002
797 MOUTH ULCERATION 5 0.0002
798 RENAL INJURY 7 0.0002
799 HAEMATOCHEZIA 13 0.0002
800 HYPOPHAGIA 6 0.0002
801 PRODUCT USE ISSUE 44 0.0002
802 ARRHYTHMIA 11 0.0002
803 ABDOMINAL PAIN 54 0.0002
804 CHILLS 27 0.0002
805 URINARY TRACT INFECTION 39 0.0002
806 GASTRITIS 6 0.0002
807 VOMITING 105 0.0002
808 AGGRESSION 11 0.0002
809 LOSS OF CONSCIOUSNESS 28 0.0002
810 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
811 RESPIRATORY ARREST 6 0.0002
812 TREATMENT FAILURE 18 0.0002
813 MENTAL STATUS CHANGES 6 0.0002
814 BLOOD TEST ABNORMAL 3 0.0002
815 ABORTION INDUCED 2 0.0002
816 HALLUCINATION 16 0.0002
817 OSTEOARTHRITIS 9 0.0002
818 SINUS TACHYCARDIA 3 0.0002
819 PARALYSIS 3 0.0002
820 RECTAL HAEMORRHAGE 9 0.0002
821 BLOOD PRESSURE FLUCTUATION 5 0.0002
822 INJECTION SITE HAEMATOMA 3 0.0002
823 ATRIAL FIBRILLATION 20 0.0002
824 CARDIOMYOPATHY 3 0.0002
825 SKIN HAEMORRHAGE 3 0.0002
826 HAEMATOCRIT DECREASED 4 0.0002
827 DELIRIUM 7 0.0002
828 DIARRHOEA 128 0.0002
829 CARDIOVASCULAR DISORDER 5 0.0002
830 FLUID RETENTION 10 0.0002
831 LUNG INFECTION 3 0.0002
832 RESTLESSNESS 7 0.0002
833 SEDATION 5 0.0002
834 DISEASE RECURRENCE 9 0.0002
835 PRODUCTIVE COUGH 9 0.0002
836 HYPOTHYROIDISM 6 0.0002
837 PLATELET COUNT DECREASED 20 0.0002
838 HYPOACUSIS 8 0.0002
839 MUSCLE TIGHTNESS 3 0.0002
840 HAEMOGLOBIN DECREASED 19 0.0002
841 PRURITUS GENERALISED 4 0.0002
842 HYPERTENSION 39 0.0002
843 CHOLELITHIASIS 6 0.0002
844 BLOOD PRESSURE DECREASED 12 0.0002
845 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
846 SOMNOLENCE 35 0.0002
847 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
848 OVERDOSE 37 0.0002
849 DYSSTASIA 5 0.0002
850 SWELLING FACE 11 0.0002
851 BLOOD GLUCOSE DECREASED 8 0.0002
852 RASH PRURITIC 9 0.0002
853 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
854 INFUSION RELATED REACTION 11 0.0002
855 COVID-19 29 0.0002
856 PELVIC PAIN 3 0.0002
857 CORONARY ARTERY DISEASE 5 0.0002
858 FEELING HOT 10 0.0002
859 MEDICATION ERROR 9 0.0002
860 CELLULITIS 8 0.0002
861 HAEMORRHAGE 16 0.0002
862 DISEASE PROGRESSION 18 0.0002
863 WHEEZING 9 0.0002
864 ABNORMAL BEHAVIOUR 6 0.0002
865 FUNGAL INFECTION 5 0.0001
866 SKIN DISORDER 5 0.0001
867 COGNITIVE DISORDER 7 0.0001
868 THERAPEUTIC RESPONSE DECREASED 9 0.0001
869 DISTURBANCE IN ATTENTION 8 0.0001
870 PRURITUS 57 0.0001
871 FEEDING DISORDER 3 0.0001
872 CONSTIPATION 32 0.0001
873 COUGH 41 0.0001
874 DYSPNOEA 81 0.0001
875 DEHYDRATION 19 0.0001
876 INJURY 10 0.0001
877 CEREBROVASCULAR ACCIDENT 24 0.0001
878 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
879 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
880 BRONCHITIS 10 0.0001
881 EYE SWELLING 5 0.0001
882 BLOOD POTASSIUM DECREASED 4 0.0001
883 PANCREATITIS 7 0.0001
884 NEPHROLITHIASIS 6 0.0001
885 TREATMENT NONCOMPLIANCE 7 0.0001
886 CHEST DISCOMFORT 13 0.0001
887 MUSCULOSKELETAL STIFFNESS 11 0.0001
888 HERPES ZOSTER 7 0.0001
889 EXTRAPYRAMIDAL DISORDER 3 0.0001
890 ABDOMINAL PAIN LOWER 3 0.0001
891 SKIN ULCER 3 0.0001
892 NEUROPATHY PERIPHERAL 11 0.0001
893 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
894 HYPERSENSITIVITY 21 0.0001
895 CARDIAC FAILURE CONGESTIVE 9 0.0001
896 DECREASED APPETITE 26 0.0001
897 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
898 FREQUENT BOWEL MOVEMENTS 3 0.0001
899 DYSURIA 4 0.0001
900 TREMOR 18 0.0001
901 FEELING COLD 3 0.0001
902 RENAL DISORDER 5 0.0001
903 PSYCHOTIC DISORDER 3 0.0001
904 DISORIENTATION 4 0.0001
905 HYPERHIDROSIS 13 0.0001
906 SUICIDE ATTEMPT 6 0.0001
907 INFLUENZA 11 0.0001
908 VERTIGO 6 0.0001
909 BLINDNESS 4 0.0001
910 LIMB DISCOMFORT 3 0.0001
911 VISUAL IMPAIRMENT 12 0.0001
912 ASTHENIA 36 0.0001
913 ECZEMA 5 0.0001
914 PARAESTHESIA 15 0.0001
915 BALANCE DISORDER 8 0.0001
916 UNEVALUABLE EVENT 7 0.0001
917 AMNESIA 6 0.0001
918 COLITIS ULCERATIVE 4 0.0001
919 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
920 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
921 CHEST PAIN 16 0.0001
922 DIZZINESS 43 0.0001
923 WEIGHT DECREASED 24 0.0001
924 NASAL CONGESTION 5 0.0001
925 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
926 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
927 MOBILITY DECREASED 6 0.0001
928 ABASIA 2 0.0001
929 INTESTINAL OBSTRUCTION 3 0.0001
930 HEADACHE 49 0.0001
931 RHINORRHOEA 5 0.0001
932 NO ADVERSE EVENT 14 0.0001
933 PLASMA CELL MYELOMA 3 0.0001
934 SPEECH DISORDER 4 0.0001
935 MUSCLE SPASMS 14 0.0001
936 DYSKINESIA 3 0.0001
937 MALAISE 32 0.0001
938 INFLUENZA LIKE ILLNESS 6 0.0001
939 POLLAKIURIA 3 0.0001
940 NAUSEA 55 0.0001
941 SINUSITIS 7 0.0001
942 ACUTE MYOCARDIAL INFARCTION 2 0.0001
943 DRY SKIN 9 0.0001
944 ANXIETY 19 0.0001
945 CHRONIC KIDNEY DISEASE 5 0.0001
946 SKIN DISCOLOURATION 3 0.0001
947 PAIN 38 0.0001
948 INSOMNIA 16 0.0001
949 FLUSHING 6 0.0001
950 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
951 INTENTIONAL PRODUCT MISUSE 5 0.0001
952 FALL 19 0.0001
953 DERMATITIS ATOPIC 3 0.0001
954 OROPHARYNGEAL PAIN 5 0.0001
955 NECK PAIN 3 0.0001
956 DEATH 46 0.0001
957 BLOOD GLUCOSE INCREASED 10 0.0001
958 DYSPHAGIA 5 0.0001
959 DIABETES MELLITUS 4 0.0001
960 BACK PAIN 12 0.0001
961 ARTHRITIS 4 0.0001
962 HEART RATE INCREASED 5 0.0001
963 INTENTIONAL OVERDOSE 3 0.0000
964 DRUG WITHDRAWAL SYNDROME 4 0.0000
965 PAIN IN EXTREMITY 13 0.0000
966 MUSCULAR WEAKNESS 5 0.0000
967 ADVERSE EVENT 4 0.0000
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
969 EMOTIONAL DISTRESS 5 0.0000
970 MYALGIA 7 0.0000
971 DYSGEUSIA 3 0.0000
972 HYPOAESTHESIA 6 0.0000
973 ARTHRALGIA 16 0.0000
974 DRY MOUTH 3 0.0000
975 PRODUCT QUALITY ISSUE 5 0.0000
976 ARTHROPATHY 2 0.0000
977 FATIGUE 28 0.0000
978 ABDOMINAL PAIN UPPER 7 0.0000
979 NASOPHARYNGITIS 6 0.0000
980 SWELLING 3 0.0000
981 WEIGHT INCREASED 7 0.0000
982 MYOCARDIAL INFARCTION 5 0.0000
983 ASTHMA 3 0.0000
984 DEPRESSION 6 0.0000
985 BLOOD PRESSURE INCREASED 4 0.0000
986 GAIT DISTURBANCE 5 0.0000
987 ABDOMINAL DISCOMFORT 4 0.0000
988 INCORRECT DOSE ADMINISTERED 5 0.0000
989 PERIPHERAL SWELLING 3 0.0000
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
992 FEELING ABNORMAL 3 0.0000